PrimeX News

Broker News

Gold Price Forecast – Hawkish Fed Comments Point to Further Downside in Metals
Thu, 18 Jun 2026 21:52:57 GMT
Space Stocks Price Forecasts: Correction or Trend Continuation?
Thu, 18 Jun 2026 23:08:09 GMT
Crude Oil Price Forecast: Will 200-Day Support Hold?
Thu, 18 Jun 2026 21:20:28 GMT
Gold (XAU/USD) Price Forecast: Can Bulls Defend Fibonacci Support?
Thu, 18 Jun 2026 20:57:01 GMT
Natural Gas Price Forecast: Will Consolidation Resolve Higher?
Thu, 18 Jun 2026 20:46:44 GMT
Silver’s Solar Paradox: Using Less, Still Running Short
Thu, 18 Jun 2026 20:21:58 GMT

First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Thu, 11 Jun 2026 17:22:12 GMT

What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Mon, 15 Jun 2026 22:36:03 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT
How Renko Charts Filter Market Noise & Improve Trend Analysis
Sun, 10 May 2026 14:02:44 GMT
Getting an Edge From Factor Investing
Sat, 09 May 2026 10:43:54 GMT

Advertisement

Advertisement

ADPT

Adaptive Biotechnologies Corporation Common Stock

17.53

USD

+0.75

+4.47%

Jun 18, 16:00 UTC -4

Closed

exchange

After-Market

17.70

+0.17

+0.97%

ADPT News & Forecasts

featured

Adaptive Biotechnologies Business Separation May Unlock Greater Value

featured

Adaptive Biotechnologies Stock Rises On Plan To Split MRD, Immune Medicine Businesses

featured

The Motley Fool

What Does an Adaptive Biotech Insider's Sale of Nearly 40,000 Shares Mean for Investors?

featured

Zacks Investment Research

Adaptive Biotechnologies (ADPT) Moves 9.7% Higher: Will This Strength Last?

featured

Adaptive Biotechnologies Highlights clonoSEQ Growth, 2026 Cash Flow Goal at Conference

featured

Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call Transcript

featured

Zacks Investment Research

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

featured

Zacks Investment Research

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates

featured

The Motley Fool

Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means

featured

The Motley Fool

Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares?

featured

The Motley Fool

Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On

featured

The Motley Fool

Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look

featured

The Motley Fool

Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year

featured

The Motley Fool

Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price

Advertisement

Advertisement

Advertisement